The role of telomeres and telomerase in stem cell aging  by Flores, Ignacio & Blasco, Maria A.
FEBS Letters 584 (2010) 3826–3830journal homepage: www.FEBSLetters .orgReview
The role of telomeres and telomerase in stem cell aging
Ignacio Flores a, Maria A. Blasco b,*
a Stem Cell Group, Cardiovascular Development Biology Program, Spanish National Cardiovascular Research Centre (CNIC), Melchor Fernández Almagro 3, Madrid, E-28029, Spain
b Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 3 Melchor Fernández Almagro Street, Madrid E-28029, Spain
a r t i c l e i n f oArticle history:
Received 9 July 2010
Revised 23 July 2010
Accepted 23 July 2010
Available online 3 August 2010
Edited by Wilhelm Just
Keywords:
Telomere
Telomerase
Stem cell
Pluripotency
p530014-5793/$36.00  2010 Federation of European Bio
doi:10.1016/j.febslet.2010.07.042
* Corresponding author. Address: Spanish Natio
(CNIO), 3 Melchor Fernandez Almagro street, Madrid
732 8028.
E-mail address: mblasco@cnio.es (M.A. Blasco).a b s t r a c t
Stem cells regenerate our bodies. In a similar manner to match ignition, stem cell ‘‘ignition’’ has to
be precisely tuned to avoid uncontrolled proliferation as may occur in tumors or, inversely, the lack
of proliferation as happens in degenerative disorders. During the last years it has become evident
that telomeres and telomerase are main components of the stem cell ‘‘ignition’’ mechanism, provid-
ing a way to restrain cancer and delay aging.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.‘‘My grandmother said that each of us is born with a box of
matches inside us but we can’t strike them all by our-
selves . . . Each person has to discover what will set off the
explosive ﬂare of a match in order to live, since the combustion
that occurs when one of them is ignited is what nourishes the
soul. If there’s nothing to trigger the explosion, our box of
matches becomes damp, and then we will never be able to light
any of them. Of course, it’s important to light the matches one
at a time. If a powerful emotion should ignite them all at once
they would produce a splendor so dazzling that it would illumi-
nate far beyond what we can normally see; and then a brilliant
tunnel would appear before our eyes, revealing the path we for-
got at birth. . .’’ (Like Water For Chocolate, Laura Esquivel,
1989)’’.
As matches nourish the soul in Laura Esquivel´s novel, stem cells
nourish our bodies. In a similar manner that match ignition, stem
cell ‘‘ignition’’ has to be precisely tuned to avoid uncontrolled pro-
liferation as may occur in tumors or, inversely the lack of prolifer-
ation responses as happen in degenerative disorders. During the
last years it has become evident that telomeres and telomerase
are main components of the stem cell ‘‘ignition’’ mechanism, pro-
viding a way to restrain cancer and delay aging.chemical Societies. Published by E
nal Cancer Research Centre
E-28029, Spain. Fax: +34 911. Maintaining telomere homeostasis
Telomeres safeguard the chromosome ends from DNA repair
and degradation activities. To accomplish this protective task a
proper telomere structure and length is required. Telomere struc-
ture is provided by binding of shelterin to telomeric repeats. Shel-
terin encompases six telomere-binding proteins with essential
roles in telomere protection and telomere length regulation [1,2].
Telomere length is established by the outcome of two opposing
forces: on one side telomere erosion generated during cell division
by the end-replication problem, exonucleases, and oxidative activ-
ities; on the other side telomere elongation by telomerase and
recombination-based processes known as alternative lengthening
of telomeres or ALT. Depending on cell type and developmental
status one force and mechanism dominates over the others. During
the early cell cycles of mouse development telomeres lengthen by
a mechanism involving sister-chromatid exchange and recombina-
tion [3]. At the blastocyst stage, telomeres are elongated by telo-
merase although telomere recombination activities are still
present, at least in embryonic stem (ES) cells cultured in vitro
[4]. In adults, telomerase maintains telomere length in young tis-
sues, but its activity decays later on life likely contributing to a
general telomere shortening [5]. Interestingly, mouse telomeres
shorten at two different rates during the course of life, slightly un-
til middle age (1-year-old) and more rapidly late in life [5]. Such bi-
phasic phase of telomere shortening parallels the decline in tissue
homeostasis observed during ageing, modest in middle-years but
abruptly at old ages [6]. A correlation between telomere length
and ageing symptoms suggests a positive role of telomere integritylsevier B.V. All rights reserved.
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telomere shortening late in life although the observed reduction in
telomerase activity likely contributes to the acceleration in telo-
mere erosion [5]. Whether telomerase activity decays with age
due to an increase in stochastic molecular damage during aging
or by the action of a temporal regulatory mechanism is a promi-
nent question for future research.2. Telomere length, telomerase and healthy life
The correlation between telomere length, telomerase activity
and healthy life has been investigated in humans. Telomere length
positively correlates with years of healthy life [7] and longevity in
Ashkenazi centenarians [8]. Importantly, a common hTERT haplo-
type associated with longer telomere length is found in Ashkenazi
centenarians and their offspring, indicating that TERT may function
as a genetic agent in life-span determination [8]. Telomerase activ-
ity also increases in adult men that adhere to a healthy diet and
perform regular exercise, conditions that led to reductions in phys-
iological distress [9]. Conversely, in chronically stressed individu-
als telomerase activity diminishes leading to acceleration in
telomere shortening [10]. Increased telomere shortening due to
mutations in the main components of the telomerase complex,
TERT, TERC and dyskerin, are found in patients with several degen-
erative disorders highlighting the importance of maintaining ade-
quate telomere reserves for living a healthy life [11]. In the case
of dyskeratosis congenita (DKC), a dominant degenerative disorder
characterized by mutations in TERT and TERC, the disease displays
features of ‘‘genetic anticipation’’ that is increasing severity and an
earlier onset in successive generations [11]. Such disease anticipa-
tion phenotype may be explained by an earlier exhaustion of telo-
mere reserves with each succeeding generation. An instrumental
role for telomere integrity in preserving organ functionality rather
than telomerase levels is illustrated in a mouse model in which
short telomeres cause degenerative defects even when telomerase
is wild-type [12,13], as well as by the recently generated mouse
models for various shelterin components [14,15] which also show
severe adult stem cell dysfunction.
3. Telomere shortening and stem cell aging
The aging process concurs with a reduction in the regenerative
capacity of various tissues, a decline in stem cell functionality and
a drop in telomere reserve. It is generally accepted that stem cell
functionality limits organ homeostasis, which in turn limits organ-
ismal longevity. It is also known in humans and mice that telo-
meres shorten with age in stem cell compartments [5,16–18].
But whether the rates of telomere shortening during physiological
aging inﬂuence stem cell functionality is a remaining question not
yet completely answered. An approximation to the former ques-
tion can be obtained using mice that lack telomerase activity. By
successive intercrossing of mice that are deﬁcient in telomerase
activity (Terc/mice), it is possible to obtain sets of mice that only
differ in their telomere length, thus providing a model system to
analyze how telomere attrition affect the behavior of different tis-
sue stem cells.
In the case of skin, epidermal stem cells (ESCs) from mice with
critically-short telomeres (G3 Terc/ mice) have been compared
with ESCs frommice that possess long telomeres (G1 Terc/mice).
Surprisingly, the number of G3 Terc/ ESCs exceeds the number of
G1 Terc/ ESCs [19]. Such accumulation of G3 Terc/ ESCs could be
explained by the presence of critically-short telomeres in ESCs
which impairs their ability to respond to stimuli with the conse-
quence of a blunted proliferation response, defects that may
underlie the premature skin aging phenotype observed in thesemice [19]. When skin from wild-type mice of different ages is
analyzed a related retention of ESC numbers throughout aging is
observed [20]. Despite similar ESC numbers in young and old-mice,
aged skin suffers from a general reduction on epidermal prolifera-
tion and loss of epidermal integrity suggesting that ESCs function-
ality declines with advanced age [20].
In the case of the bone marrow, the presence of short telomeres
in G3 Terc/ long-term reconstituting hematopoietic stem cells
(LT-HSCs) reduces their ability to repopulate irradiated mice. Such
decline in regenerative function is exacerbated in old G3 Terc/
HSCs, even though the HSC pool expands with age in these mice
[21]. A direct function of telomere shortening per se (and not telo-
merase activity) in limiting proliferation is illustrated by a decrease
in the number and growth of colony-forming units (cfu) formed
in vitro in G3 Terc/ compared to G1 Terc/ bone marrow cell sus-
pensions [22]. Similarly to ESC in skin, the increased frequency of
LT-HSCs in old mice may reﬂect an accumulation of defective LT-
HSCs during aging [23]. Indeed, the vast majority of LT-HSCs from
old wild-type mice stain for phosphorylation of histone H2AX, a
marker of the DNA-damage-response, indicating that DNA damage
accumulates in stem cells with age [21].
Similar conclusions can be derived from studies in the gut
where crypt apoptotic bodies increased progressively in each suc-
cessive generation of G1 to G3 Terc/ [22]. Finally, the deleterious
effect of telomere shortening is not limited to high turnover tissues
since the adult brain of late-generation telomerase-deﬁcient
mouse shows a reduction in its neural stem cells (NSC) prolifera-
tion and differentiation capacities [17,24].4. Sensing telomere damage in stem cell populations
The tumor suppressor protein p53 is a major sensor of cellular
stress, including telomere damage. Upon extreme telomere short-
ening in late-generation telomerase-deﬁcient mice, p53 is acti-
vated in skin and gut leading to a proliferation arrest and an
apoptosis response, respectively [22,25]. Interestingly, the major-
ity of p53-positive cells accumulate within the stem/progenitor
compartments in both tissues, suggesting that p53 is activated in
stem/progenitor cells in the presence of short telomeres [25,22].
Increased levels of nuclear p53 are also detected in adult NSCs de-
rived from late-generation telomerase-deﬁcient mice [24].
To address the contribution of p53 activation in mediating stem
cell functionality defects triggered by short telomeres, several
groups have generated late-generation telomerase-deﬁcient mice
in a p53 null background. In pioneering experiments, Chin et al.
demonstrated that the absence of p53 rescues the germ cell deple-
tion associated with telomere dysfunction in late-generation
mTerc/ mice, suggesting that p53 senses telomere damage in
stem/progenitor cell populations and leads to massive germ cell
apoptosis [26]. More recently, we showed that p53 ablation res-
cues the mitogen induced hair and skin growth responses, at the
same time that it corrects epidermal stem cell (ESC) activation in
telomere-dysfunctional mice [25]. Ferrón et al. determined that
p53 deletion not only rescues neural stem cell proliferation defects
but also differentiation defects of adult neural progenitors with
dysfunctional telomeres [17]. Finally, Begus-Nahrmann et al. have
shown that the lack of p53 impairs the depletion of intestinal stem
cells leading to an increase of chromosomal instability in basal
crypts and premature intestinal failure of aging mice with short
telomeres [27]. Therefore, the middle-term effect of p53 deletion
in mice with short-term telomeres depends in the tissue, beneﬁcial
in testis, skin and brain, and detrimental in gut. Yet, since p53 dele-
tion in late generation telomerase deﬁcient mice ultimately leads
to accelerated tumor formation, the overall data suggest that such
p53-dependent checkpoint acting on stem cells in these mice col-
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mor progression.
5. ‘‘Live fast, die young’’ vs. ‘‘Live slow, die old and, with help,
very old’’
Unfortunately many talented human beings have fallen victim
to the philosophy ‘‘live fast, die young’’. In the case of famous
pop and rock stars a recent study reports that their chances of pre-
mature death double the ones of the rest of the population [28].
Although not reaching anxiety levels, depression and drug use
sometimes present in this ‘‘high-risk’’ profession, common modern
lifestyles tend to bring high levels of psychological and physiolog-
ical stress. How stress inﬂuences our cells at the molecular level is
unknown, but telomerase activity and telomere length may be po-
tential mediators. Higher levels of perceived psychological stress in
humans concurs with low levels of telomerase activity and shorter
telomeres [10]. Risk of cardiovascular diseases and higher mortal-
ity rates are also associated with short telomeres [29,30]. In the tel-
omerase knockout model, a progressive reduction in life span
parallels a progressive reduction in telomere length as generations
without Terc increases [22,31]. Collectively, these data suggest that
telomerase and telomere length are rate-limiting for human and
mice life-span.
To avoid the exhaustion of telomere reserves and to test the
inﬂuence of telomere-maintenance mechanisms in life-span, telo-
merase has been constitutively expressed in several transgenic
mice. Initial studies showed that forced-expression of telomerase
moderately expands maximum life-span but at the cost of
slightly higher rates of tumor formation early in life [32]. More
recent studies from our group have prevented the telomerase
protumorigenic activities by overexpressing Tert, the catalytic
component of telomerase, in a tumor-resistant genetic back-
ground [33]. In mice with extra-Tert and extra copies of the
tumor suppressors genes p53, Ink4a and ARF, the potential of
telomerase in delaying aging was unmasked with the ﬁnal
outcome of an increase in median life expectancy up to 40% com-
pared to controls [33]. It is important to remark that the life-span
expansion is not due to cancer protection because when longevity
was compared considering only those mice that do not succumb
by tumors the difference in life expectancy between the quadru-
plet transgenics and controls was maintained [33]. In agreement
with the beneﬁcial longevity effect, the number of degenerative
pathologies decreases at old ages in these compound mice. In
addition, telomere reserves in stem cell compartments and prolif-
eration potential of stem cells are better preserved, which could
explain at the molecular level the antiaging effect of telomerase.
Interestingly, a modest increase in Ink4a/Arf/p53 genes under
their natural regulation and during the entire life of the mouse
also has a positive effect on telomere and stem cell preservation
[33].
Considering the above results, we propose a simpliﬁed model of
life extension in which the time-point of tissue homeostasis failure
is determined by the pace of stem cell division and the number of
stem cell divisions permitted before stem cell telomeres become
critically-short (see Fig. 1). Given that tumor suppressors restrain
the proliferation of adult stem cells as well as may prevent accu-
mulation of stem cells with DNA damage [34], stem cells carrying
extra tumor-suppressor would present a lower rate of stem cell
division, thus prolonging tissue homeostasis by ‘‘living slow’’. On
top of that, telomerase would further extend life-span by main-
taining telomeres above their critically-short length and therefore
increasing the permissible number of stem cell divisions. Besides
telomerase other factors may determine stem cell division at old
ages since Tert forced-expression, although produces immortal
cells, does not produce immortal mammals.6. Delaying ageing avoiding telomere loss
According to the model presented in Fig. 1, treatments that help
to maintain telomere length would produce beneﬁcial effects in
life-extension. One way to preserve telomere integrity would be
elongating telomeres by activating telomerase; another non-exclu-
sive way would be inhibiting telomere attrition indirectly by slow-
ing-down the rate of stem cell division.
Natural interventions and drugs can activate telomerase. Specif-
ically, physical activity, healthy diet and stress management aug-
ments telomerase activity in middle-age men and old women
[9,35]. In addition, chemical telomere activators have been shown
to act in vitro and experiments in vivo are underway [36]. Further-
more, moderate increases in the expression of genes involved in
growth arrest, i.e., p21, in stem cells could be a plausible option
to lower the rate of stem cell division and consequently delay
exhaustion of telomere reserves. Indeed, small molecules that tar-
get the Mdm2-p53 interaction, elevating p21 levels, have already
been characterized, showing in vivo activity [37]. Interestingly,
reduction in bone thickness, one of the hallmarks of aging, is ame-
liorated in mutant mice with a partial reduction in Mdm2 activity,
which supports a beneﬁcial effect for long-term tissue homeostasis
in disrupting Mdm2-p53 interactions [38].7. The longest telomeres as a marker for adult stem cells
The main causes of telomere shortening are oxidative activities
at the telomeres and the incomplete replication of telomeric DNA
during cell division, the so-called ‘‘end-replication problem’’, attri-
tion mechanisms that can be counteracted by the enzyme telome-
rase. In adults, telomerase is only expressed in germ cells, stem
cells and some progenitor cells [39]. Furthermore, stem cells divide
very infrequently and reside in speciﬁc microenvironments or
niches that are protected from oxidative damage and other damag-
ing agents [40], suggesting a low rate of telomere erosion through-
out their life-time. A prediction from these observations is that
those cells with the longest telomeres within a given tissue may
correspond to the most primitive stem cell population.
We have recently generated topographic telomere length maps
in tissue sections to examine the former prediction. Telomere maps
performed in skin, small intestine, brain, cornea and testis sections
show gradients of telomere length, with the longest telomeres gen-
erally marking the most primitive adult stem cell compartments
and the shortest telomeres in the more differentiated compart-
ments within a given tissue [5]. Other authors have conﬁrmed
some of these ﬁndings studying the gut and reported similar re-
sults in lingual epithelium [18,41]. Since telomere cell hierarchies
are general features of almost all adult organs, identiﬁcation of
the longest telomeres may be useful in identifying new stem cell
compartments. Indeed, we have recently deﬁned a stem cell niche
in the pituitary by combining telomere length measurements with
other expression markers [42].
The correct identiﬁcation and characterization of stem cell
niches in healthy and disease conditions could lead to new clinical
applications. In particular, stem cells have gained importance as
the population of cells that tumors arise from, the so-called ‘‘cancer
stem cells’’ [43]. The ability to identify this population will enable
to monitor their behavior in response to different stimuli or thera-
peutic treatments, as well as to study the molecular changes with-
in stem cells that lead to tumorigenesis.8. Telomerase, telomeres, and pluripotency
Mouse and human Embryonic stem (ES) cells are pluripotent,
proliferate indeﬁnitely and bear very long telomeres owe to high
Fig. 1. Extra telomerase and extra tumor suppressors increase the life span of mice.
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considered one of the landmarks of the pluripotent state. ES-like
pluripotent stem cells have been recently generated from differ-
entiated cells (i.e., MEFs) by using deﬁned factors giving rise the
so-called induced pluripotent stem (iPS) cells, which are consid-
ered functional equivalents of ES cells and also have high TERT
expression [47–54]. Like ES cells, iPS cells are able to contribute
to embryonic mouse development and to the mouse germline as
well as share similar genome-wide epigenetic proﬁles
[47,48,52,55,56]. We recently showed that iPS telomeres increase
in length during and post nuclear reprogramming until reaching
ES cell hyper-long telomeres, concomitant with a low density of
trimethylated histones H3K9 and H4K20 at telomeric chromatin
and an increased abundance of telomere transcripts, the so-
called TERRA [56]. Importantly, telomere lengthening was not
observed in iPS cells derived from ﬁrst generation telomerase-
deﬁcient MEFs indicating that presence of hyper-long telomeres
in iPS cells was not due to a selection of cells with very long
telomeres already present at in parental MEFs population but,
instead, it was due to an active telomere elongation by telome-
rase during and post nuclear reprogramming [56]. Importantly,
we observed that the reprogramming efﬁciency of cells derived
from increasing generations of telomerase deﬁcient mice is
drastically reduced, and this defect is corrected after telomerase
reintroduction [56]. The fact that cells with short telomeres are
not subject to nuclear reprogramming suggests the existence of
some ‘‘reprogramming barriers’’ aborting the reprogramming of
suboptimal parental cells bearing dysfunctional telomeres. In
this regard, reprogramming in the face of pre-existing but toler-
ated DNA damage is aborted by the activation of the p53-depen-
dent DNA damage response (DDR) and apoptosis. In particular,
during reprogramming iPS cells increase their intolerance to
the different types of DNA damage and p53 is critical to avoid
generation of iPS cells from suboptimal parental cells [57]. Final-
ly, given that certain reprogramming factors promote in vivo
tumorigenesis, it is tempting to propose that the DDR observed
in cultures of p53 deﬁcient cells might be equivalent to the
oncogene-induced DDR that takes place during malignant trans-
formation. For the two scenarios, nuclear reprogramming and
transformation, p53 is critical for controlling the dissemination
of damaged cells.Our results highlight the importance of telomere biology in the
generation and in the functionality of iPS cells, and they have
important implications for the clinical translation of iPS cells tech-
nologies, particularly so in those patients afﬂicted with the so
called ‘‘telopathies’’.
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